THE EVIDENCE

Steripath Independent Clinical Study Results

Reduction in Blood Culture Contamination (%)
Steripath Reduction Chart
%

These institutions reduced their blood culture contamination rates by an average of 83.8% when using Steripath® vs. standard practice (baseline)

Explore the results for yourself

Mass General, Harvard Medical School, Wing Tech
Journal of Hospital Infection
Published Date: March 2019
>> Peer-Reviewed Conclusion: The use of Steripath ISDD is the single most effective intervention so far explored for reducing costs related to false-positive blood cultures, and would save the average hospital (250-400-bed hospital) $1.9M or $186 per blood culture, and prevent 34 HACs, including 3 C. difficile cases.
Read More >
JCM Journal Cover
University of Houston College of Pharmacy
Journal of Clinical Microbiology
Published Date: October 2018
>> Peer-Reviewed Conclusion: The findings support the routine use of ISDD during blood culture collection in the ED as a cost-beneficial strategy to reduce the clinical and economic impact of blood culture contamination in terms of microbiology, pharmacy and wider indirect hospital impact.
Read More >
University of Nebraska Medical Center
University of Nebraska Medical Center
Clinical Infectious Diseases
Published Date: July 2017
>> Peer-Reviewed Conclusion: Use of the ISDD was associated with a significant decrease in blood culture contamination in patients undergoing blood cultures in an Emergency Department setting.
Read More >
Lee Health
Journal of Emergency Nursing
Published Date: April 2018
>> Peer-Reviewed Conclusion: This unique collection system can reduce the risk of blood culture contamination significantly and is designed to augment, rather than replace, the standard phlebotomy protocol already in use in most health care settings.
Read More >
Shaare Zedek Medical Center
American Journal of Infection Control
Published Date: January 2019
>> Peer-Reviewed Conclusion: This controlled clinical study showed an 81% reduction in blood culture contamination with a 6-month sustained rate of 1.0% (P=0.008) when Steripath was used to collect blood cultures via both venipuncture and at the time of peripheral IV start compared to a rate of 5.2% when standard method was used.
Read More >
Rush University Medical Center
IDWeek 2017
Conclusion: The use of the SP device in the ED over a 3-month period significantly reduced the rate of blood culture contamination from 4.3% to 0.6% while the rates of true bacteremia remain unchanged. The SP device represents a simple and effective method for reducing blood culture contamination.
Read More >
San Antonio Military Medical Center
San Antonio Military Medical Center
Department of Defense Healthcare Quality and Safety Award Winner 2016
Conclusion: Data indicates use of SteriPath significantly reduces contamination rates. Approximately $5,000 per false positive result. BAMC has saved over $235,000 since September 2015 by utilizing SteriPath in Emergency Department.
Read More >
San Antonio Military Medical Center
San Antonio Military Medical Center
Society for Healthcare Epidemiology of America 2017
Conclusion: Empiric vancomycin usage decreased after implementation of a molecular detection assay and diversion blood collection methods. While both pre and post-analytic methods decrease vancomycin use, greater de-escalation was best achieved through a combination of methods.
Read More >
Beebe Healthcare
American Society for Microbiology, 2018
Conclusion: Use of the ISDD device led to a significant decrease in the BCC rate in all groups that participated in the trial: ED, ICU, and phlebotomy team. The contamination rate for specimens collected with the ISDD was 0.76%, which is a 73% reduction compared to the historical rate of 2.8%.
Read More >
Medical University of South Carolina
Medical University of South Carolina
Institute for Healthcare Improvement 2017
Conclusion: ISDD use decreased FPBCs below 1% in a busy adult ED, well below the national benchmark of 3%, and the reduction in FPBC has been sustained for 20 months. Reducing FPBCs has led to reduced related costs and more efficient use of staff time, while helping to comply with national/international efforts to improve antibiotic stewardship and patient safety.
Read More >
Medical University of South Carolina
Medical University of South Carolina
Institute for Healthcare Improvement 2016
Conclusion: The SteriPath device successfully reduced the number of FPBC over the 8-month trial period (average of 0.57% with vs 4.17% without). We suspect that vendor training lead to an increased focus on proper BC collection technique by all nursing personnel, resulting in a 50% decrease in FPBC rate for all adult ED BC (4.6% in FY2015 to 2.3% in FY2016).
Read More >
Michael E. DeBakey VA Medical Center - Houston
Emergency Nurses Association, 2018
Conclusion: ER ISDD use resulted in a 83% decrease compared to UC (P=.01). ER study supported Leadership decision to implement the ISDD hospital-wide. High use areas [Acute care, Medical, Surgical, Prime Care, Phlebotomy and ER] began ISDD use October, 2017. As utilization of ISDD has increased, and with the conversion to the second generation ISDD, hospital-wide BCC rates have continued to decrease.
Read More >
Evidence presented as a Green Belt Project 2016
VA - North Texas Health Care System
Green Belt Project 2016
Conclusion: A post-Steripath adoption blended (combined Steripath and standard method results) blood culture contamination rate of 1.7% at 50% compliance compared to a pre-Steripath implementation of 5.3%, representing a 69% reduction. Steripath enabled a 45% reduction in blood culture collection steps and an estimated savings of $332,500 over a five month period.
Read More >

Make an impact at your hospital by reducing blood culture contamination

Continue Reading
The Problem

Learn about the consequences of false-positive blood cultures

Read More >
The Challenge

What differentiates Steripath Gen2 from other techniques and methods

Read More >
Steripath Gen2

Blood culture collection & contamination prevention system

Read More >
The Benefits

The clinical & economic impact of reducing blood culture contamination

Read More >